Nemaura Medical Inc.

NMRD · OTC
Analyze with AI
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Operating Activities
Net Income-$14,144-$13,887-$6,259-$4,160
Dep. & Amort.$444$230$98$55
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$221$113$565
Change in WC-$2,054-$175-$1,958$78
Other Non-Cash$7,302$7,107$2,008$13
Operating Cash Flow-$8,452-$6,504-$5,998-$3,450
Investing Activities
PP&E Inv.-$376-$956-$836-$211
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$163$0$0$0
Investing Cash Flow-$539-$956-$836-$211
Financing Activities
Debt Repay.-$5,574-$12,400$24,400$0
Stock Issued$8,394$3,119$15,751$152
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$738$2,913-$2,164-$55
Financing Cash Flow$2,082-$6,368$37,986$97
Forex Effect-$735-$287$607-$71
Net Chg. in Cash-$7,644-$14,116$31,759-$3,635
Supplemental Information
Beg. Cash$17,749$31,865$106$3,741
End Cash$10,105$17,749$31,865$106
Free Cash Flow-$8,991-$7,461-$6,835-$3,661